Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostatic Neoplasms × Glycyrrhizic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 51 Specimen Handling 40 enzalutamide 37 Androgen Antagonists 35 Radiotherapy 31 Radiosurgery 31 darolutamide 27 Prednisone 26 Abiraterone Acetate 26 Docetaxel 23 Leuprolide 21 apalutamide 19 Pluvicto 19 abiraterone 18 Standard of Care 18 Radiation 17 Triptorelin Pamoate 16 Goserelin 15 Biopsy 15 relugolix 14 gallium 68 PSMA-11 14 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 14 Blood Specimen Collection 14 Surveys and Questionnaires 13 pembrolizumab 10 X-Rays 10 Methods 10 Educational Status 10 Early Intervention, Educational 10 Carboplatin 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06378346 2026-02-23

GU-01

University of Illinois at Chicago

Phase 2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡